There is a newer version of the record available.

Published July 20, 2023 | Version v1
Journal article Open

A Systemic Summary of Nanotechnology's Current and Prospective Scope in Drugs Delivery

Description

The creation of drug formulations based on
nanoparticles offers the possibility to tackle and treat
challenging diseases. The size of nanoparticles varies
between 100 and 500 nm. By changing their size, surface
characteristics, and structure, nanoparticles can be
transformed into intelligent systems. The idea was put
forth as a workable substitute with the ability to target
and administer drugs. The use of nanobiotechnology in
viral, autoimmune, and inflammatory diseases is
numerous. Nanoparticles have biomimetic properties
like medication formulation and encapsulation.
Nanomaterials are substances based on graphene for
stem cell and tissue engineering constitute a few of the
most contemporary graphene developments.

Files

IJISRT23JUL392.pdf

Files (493.0 kB)

Name Size Download all
md5:5768f029ca37b5be8433f31b469137cf
493.0 kB Preview Download